drugset / Trial / NCT05001776

Endovenous Laser Ablation in Acute Thrombophlebitis of the Varicose Great Saphenous Vein

NCT05001776

RandomizedParallel-groupOpen-labelTreatment

Summary

Рrospective single-centre randomized open-label study for comparison three modes of treatment for thrombosis of varicose great saphena vein - standard medical with fondaparinux sodium for 45 days, endovenous laser ablation close to the saphenofemoral junction with a 7-day course of anticoagulation and endovenous laser ablation close to the saphenofemoral junction without the use of anticoagulants.

Timeline

Start
2021-08-16
Primary completion
2023-12-01
Completion
2023-12-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fondaparinux Other / unclassified Subcutaneous

Indications